The current valuation score of PDS Biotechnology Corp is 6.01, ranking 381 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.35, which is 0.00% below the recent high of -0.35 and -2326.48% above the recent low of -8.39.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.